Wexford Capital LP Akouos, Inc. Transaction History

Wexford Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.46 - $5.2 $49,200 - $104,000	20,000 Added 40.0%	70,000 $328,000
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $215,370 - $320,381	28,153 Added 128.86%	50,000 $425,000
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $170,300 - $224,500	10,000 Added 84.41%	21,847 $433,000
Q3 2020 Nov 16, 2020	BUY	$19.3 - $26.92 $218,997 - $305,461	11,347 Added 2269.4%	11,847 $271,000
Q2 2020 Aug 13, 2020	BUY	$22.0 - $22.5 $11,000 - $11,250	500 New	500 $11,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.